Thomas Dubin

Thomas Dubin

Director/Miembro de la Junta en INTENSITY THERAPEUTICS, INC. .

Fortuna: - $ al 31/05/2026

64 años
Health Technology
Consumer Services
Commercial Services

Perfil

Thomas I.
H.
Dubin
is Executive Chairman at Cellphire, Inc., Director at Norwalk Health Services Corp., Independent Director at Intensity Therapeutics, Inc. since 2024, and Member at Yale School of Public Health.
Former roles include Independent Director at Bioblast Pharma Ltd. from 2015 to 2018, Independent Director at Notable Labs Ltd. from 2023 to 2024, Assistant General Counsel-Pharmaceuticals at Warner-Lambert Co. from 1992 to 1999, Secretary, Vice President & General Counsel at ChiRex, Inc. from 1999 to 2000, Chief Legal Officer, Senior VP & General Counsel at Alexion Pharmaceuticals, Inc. in 2011, Corporate Attorney at Cravath, Swaine & Moore LLP, and Treasurer & Trustee at American Jewish World Service, Inc. Education includes graduate studies at Yale University and New York University School of Law, and undergraduate studies at Amherst College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/04/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Thomas Dubin

EmpresasCargoInicio
INTENSITY THERAPEUTICS, INC. Director/Miembro de la Junta 14/05/2024
Director/Miembro de la Junta -
Presidente -
Corporate Officer/Principal -

Antiguos cargos conocidos de Thomas Dubin.

EmpresasCargoFin
Director/Miembro de la Junta 31/07/2018
ALEXION PHARMACEUTICALS, INC. Consejero General -
Consejero General 01/09/2000
Corporate Officer/Principal 01/01/1999
Ver el detalle de la experiencia de Thomas Dubin.

Formación de Thomas Dubin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Commercial Services

Consumer Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN